Special Issue "Vision and the Immune System"

A special issue of Biology (ISSN 2079-7737). This special issue belongs to the section "Immunology".

Deadline for manuscript submissions: 30 April 2024 | Viewed by 66

Special Issue Editor

1. School of Molecular Sciences, Arizona State University, Phoenix, AZ 85004, USA
2. College of Health Solutions, Arizona State University, Phoenix, AZ 85004, USA
Interests: rhodopsin; retinitis pigmentosa; protein structure; dynamics; function and interactions; G protein coupled receptors; membrane proteins; pharmacology of non-model organisms; systems biology of pollutants; genotype to phenotype mapping

Special Issue Information

Dear Colleagues,

Vision is one of the most important senses, and the loss of vision has devastating consequences on one’s quality of life. Rhodopsin is the primary photoreceptor in mammalian dim-light vision, and mutations in rhodopsin have been associated with retinal degeneration. Over a decade ago, we predicted that rhodopsin interacts with chemokines based purely on the machine learning integration of large-omics datasets. At the time, the prediction seemed absurd, considering the established function of rhodopsin in vision and chemokines in the immune system. Since then, evidence has been mounting that vision and immune functions are interconnected systems within the human body in general, not just involving rhodopsin. On the one hand, the immune system safeguards the eyes from infections but also contributes to allergies, autoimmune disorders, and the degeneration of the retina in diseases such as diabetic retinopathy and retinitis pigmentosa. While the retina can attract immune cells, it also produces them. Understanding these systems’ relationships is essential for maintaining eye health and overall well-being. We would like to invite review and original contributions aimed at delineating these interconnections. Given the interdisciplinary nature of this topic, submitted papers may also be focused on areas of research and/or methodologies that may be applicable to address the topic, even if they have not yet been applied.

Prof. Dr. Judith Klein-Seetharaman
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • chemokine, cytokine and other immune-function-related proteins and non-coding RNAs in the retina
  • retinal organoids
  • rodent models
  • zebrafish
  • fruit fly
  • human patients
  • database mining
  • data-driven discovery of biological functions
  • non-image-forming functions of opsin receptor proteins
  • retinal degeneration
  • Muller glia cells
  • retinal pigment epithelium

Published Papers

This special issue is now open for submission.
Back to TopTop